Extracorporeal hemoadsorption with the CytoSorb device as a potential therapeutic option in severe intoxications: Review of the rationale and current clinical experiences
- PMID: 35924306
- DOI: 10.1111/jcpt.13724
Extracorporeal hemoadsorption with the CytoSorb device as a potential therapeutic option in severe intoxications: Review of the rationale and current clinical experiences
Abstract
What is known and objective: Many severe intoxications occur with substances with no specific antidote, which is why methods of extracorporeal elimination represent a particularly useful and even critical component in their management. The purpose of this review is to summarize the accumulating evidence and clinical results from the application of CytoSorb hemoadsorption therapy in patients with severe intoxications.
Comment: The technology represents a promising technique with an increasing number of publications in a variety of severe intoxication scenarios suggesting that early intervention might provide rapid substance removal with subsequent overall clinical improvement.
What is new and conclusion: Given the tremendous challenges in performing prospective, randomized trials in this field, the strong safety profile of the device and the high acuity of these life-threatening situations, CytoSorb should be considered as a therapeutic option in severe intoxications, particularly when direct antidotes are not available. However, further clinical data are desirable to provide precise recommendations.
Keywords: CytoSorb; blood purification; drug; hemoadsorption; intoxication.
© 2022 John Wiley & Sons Ltd.
References
REFERENCES
-
- Gummin DD, Mowry JB, Beuhler MC, et al. 2019 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th annual report. Clin Toxicol. 2020;58:1360-1541.
-
- Emergency Management of Poisoning. Haddad and Winchester's clinical management of poisoning and drug overdose; 2007:13-61.
-
- Kim Z, Goldfarb DS. Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract. 2010;115:c1-c6.
-
- Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The role of renal replacement therapy in the Management of Pharmacologic Poisonings. Int J Nephrol. 2016;2016:3047329-3047312.
-
- Bernardi MH, Rinoesl H, Dragosits K, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016;20:96.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
